```json
{
"content": [
{
"type": "paragraph",
"content": "North America dominates the Azvudine market with a 30% share, driven by high adoption rates in advanced healthcare systems, robust R&D investments, and supportive regulatory frameworks. The region is forecasted to maintain steady growth due to its mature biotech ecosystem and aging demographics increasing demand for antiviral therapies."
},
{
"type": "paragraph",
"content": "Europe follows with a 25% share, propelled by stringent pharmaceutical policies, strong public healthcare infrastructure, and collaborative research initiatives. The Azvudine market growth in Europe is further accelerated by rising investments in clinical trials and a focus on precision medicine."
},
{
"type": "paragraph",
"content": The Asia Pacific region leads in growth momentum, projected to expand at the fastest CAGR. Factors include improving healthcare access in emerging economies, rising disposable incomes, and aggressive pharmaceutical industry expansion. Government initiatives to combat infectious diseases and partnerships with global players are key enablers."
},
{
"type": "paragraph",
"content": "Latin America (15% share) and Middle East & Africa (10% share) exhibit slower growth but show potential due to improving infrastructure and cross-border R&D collaborations. Policy reforms in Latin America and targeted public health programs in the Middle East & Africa could drive incremental adoption."
}
],
"worldMapData": {
"regions": [
{ "name": "North America", "value": 30 },
{ "name": "Europe", "value": 25 },
{ "name": "Asia Pacific", "value": 20 },
{ "name": "Latin America", "value": 15 },
{ "name": "Middle East & Africa", "value": 10 }
]
}
}
```
